Concord Drugs Ltd

NSE: BSE: 538965

₹79.68

(1.51%)

Mon, 21 Sept 2026, 02:32 am

MTF 5xInvest in Concord Drugs Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)0

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Concord Drugs News

Concord Drugs FY26 profit rises 215%

Concord Drugs reported a consolidated net profit of ₹105.50 lakh for FY26, up from ₹33.62 lakh in the previous year. Revenue from operations surged to ₹7,877.13 lakh.

27 May 2026

companies

Concord Drugs submits quarterly certificate to BSE

Concord Drugs Limited submitted Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31, 2026 through R&T Agent Aarthi Consultants.

10 Apr 2026

companies

Concord Drugs confirms non-LC status under SEBI rules

Concord Drugs Limited informs BSE that it does not qualify as Large Corporate under SEBI debt securities framework as on March 31, 2026, exempting it from related compliance requirements for FY2025-26.

10 Apr 2026

companies

Concord Drugs confirms non-LC status under SEBI rules

Concord Drugs Limited informs BSE that it does not qualify as Large Corporate under SEBI debt securities framework as on March 31, 2026, exempting it from related compliance requirements.

10 Apr 2026

companies

Concord Drugs Q3FY26 Revenue Jumps 56.5% to ₹1,686.13 Lakhs

Concord Drugs Limited reported strong Q3FY26 results with revenue rising 56.5% to ₹1,686.13 lakhs. Net profit increased to ₹21.52 lakhs from ₹22.19 lakhs in Q3FY25, while nine-month revenue reached ₹4,032.00 lakhs.

17 Feb 2026

co actions results

Showing 1–5 of 12

Rows per page:

Market Current News

Multi Commodity Exchange plans analyst meet on Sep 24

Multi Commodity Exchange of India has scheduled a meeting with analysts and investors on September 24.

18 Sept 2026

commodities

Axiom Gas Engineering IPO Day 1: Subscription at 0.61x

Axiom Gas Engineering IPO opens on Day 1 with a total subscription of 0.61x. QIBs lead at 0.80x, while Retail stands at 0.63x. Check full category-wise breakdown and offer details.

18 Sept 2026

ipo

India raises sugar stock limit for bulk buyers

The Indian government has doubled the stockholding limit for bulk sugar buyers from 15 to 30 days. The move aims to stabilize supply chains. Traders are also urged to pass on price savings to consumers.

18 Sept 2026

commodities

Elevate Campuses IPO: ₹1,850 Cr Issue

Elevate Campuses files DRHP for ₹1,850 crore IPO to fund K-12 acquisitions and debt repayment. The student housing leader reports ₹806.93 crore FY26 revenue.

18 Sept 2026

ipo

Swastika Infra IPO DRHP: ₹129 Cr Fresh Issue

Swastika Infra files DRHP for ₹129 crore fresh issue. The EPC firm reports ₹503.57 crore revenue in FY26 with 55% CAGR. Funds to meet working capital needs.

18 Sept 2026

ipo

Showing 1–5 of 94305

Rows per page: